Provided by Tiger Trade Technology Pte. Ltd.

Pacira Pharmaceuticals

21.77
+0.32001.49%
Post-market: 21.770.00000.00%17:21 EST
Volume:766.68K
Turnover:16.88M
Market Cap:894.75M
PE:46.19
High:22.45
Open:21.47
Low:21.47
Close:21.45
52wk High:27.64
52wk Low:18.80
Shares:41.10M
Float Shares:37.84M
Volume Ratio:1.14
T/O Rate:2.03%
Dividend:- -
Dividend Rate:- -
EPS(TTM):0.4713
EPS(LYR):-2.1529
ROE:2.90%
ROA:2.89%
PB:1.23
PE(LYR):-10.11

Loading ...

Is Pacira BioSciences, Inc.'s (NASDAQ:PCRX) Stock Price Struggling As A Result Of Its Mixed Financials?

Simply Wall St.
·
Feb 13

BRIEF-Pacira Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

Reuters
·
Feb 09

Pacira Biosciences Grants Inducement Equity Awards to New Employees

Reuters
·
Feb 09

Pacira Biosciences Chief Administrative Officer Kristen Williams Reports Disposal of Common Shares

Reuters
·
Feb 04

Pacira Biosciences Files Initial Beneficial Ownership Statement for Director Samit Hirawat

Reuters
·
Jan 30

Pacira appoints Samit Hirawat to board of directors

TIPRANKS
·
Jan 28

Pacira Biosciences Appoints Samit Hirawat to Board of Directors

Reuters
·
Jan 28

Press Release: Pacira BioSciences Appoints Samit Hirawat, M.D., to Board of Directors

Dow Jones
·
Jan 28

Analysts Are Bullish on These Healthcare Stocks: Pacira Pharmaceuticals (PCRX), Inspire Medical Systems (INSP)

TIPRANKS
·
Jan 23

Pacira Biosciences Inc - to Receive Upfront Payment and Royalties From LG Chem

THOMSON REUTERS
·
Jan 13

Pacira Biosciences Inc - LG Chem Gains Exclusive Rights to Commercialize Exparel

THOMSON REUTERS
·
Jan 13

Pacira Announces Agreement with LG Chem to Make EXPAREL® Available in Select Asian-Pacific Markets

GlobeNewswire
·
Jan 13

Pacira BioSciences (PCRX) Is Down 6.3% After Cut 2025 Outlook And Activist Pressure - Has The Bull Case Changed?

Simply Wall St.
·
Jan 12

Assessing Pacira BioSciences (PCRX) Valuation After Record EXPAREL Quarter Buybacks And Activist Pressure

Simply Wall St.
·
Jan 10

Stock Track | Pacira Pharmaceuticals Plummets 13.37% Intraday After Reporting Preliminary FY25 Revenue Results

Stock Track
·
Jan 10

Crude Oil Rises Sharply; US Consumer Sentiment Edges Higher In January

Benzinga
·
Jan 10

Analysts Offer Insights on Healthcare Companies: Zymeworks (ZYME), Pacira Pharmaceuticals (PCRX) and Beta Bionics, Inc. (BBNX)

TIPRANKS
·
Jan 09

Pacira BioSciences Is Maintained at Buy by Needham

Dow Jones
·
Jan 09

Stocks to Watch: Cemtrex, Olin, Pacira BioSciences, Tilray Brands

Dow Jones
·
Jan 09

Pacira BioSciences Falls After Preliminary Sales Miss Estimates

Dow Jones
·
Jan 09